I.M. Sechenov First Moscow State Medical University
🇷🇺Russia
CI-AKI in Patients With Stable CAD and Comorbidities. Are we Doing Better?
Completed
- Conditions
- Stable AnginaAcute Kidney InjuryContrast-induced Nephropathy
- Interventions
- Procedure: Iodinated contrast media
- First Posted Date
- 2019-07-10
- Last Posted Date
- 2019-10-29
- Target Recruit Count
- 1023
- Registration Number
- NCT04014153
Clinical Evaluation of Effectiveness and Safety of Amberen and Smart B in Perimenopausal Women.
Not Applicable
Completed
- Conditions
- Perimenopause, Climacteric Syndrome
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: AmberenDietary Supplement: Smart B
- First Posted Date
- 2019-04-01
- Last Posted Date
- 2020-02-20
- Target Recruit Count
- 106
- Registration Number
- NCT03897738
- Locations
- 🇷🇺
Sechenov First Moscow Medical University, Moscow, Russian Federation
Benign Prostatic Hyperplasia and Ischemic Heart DIsease
Phase 4
Completed
- Conditions
- Ischaemic Heart Disease (IHD)Benign Prostatic Hyperplasia (BPH)Lower Urinary Tract Symptoms (LUTS)
- Interventions
- Procedure: TURP
- First Posted Date
- 2019-02-27
- Last Posted Date
- 2019-02-27
- Target Recruit Count
- 83
- Registration Number
- NCT03856242
Micro-RNA Profile in Patients With Different Stages of Atherosclerosis According to CTA
Not Applicable
Completed
- Conditions
- AtherosclerosisIschemic Heart Disease
- Interventions
- Diagnostic Test: blood test
- First Posted Date
- 2019-02-27
- Last Posted Date
- 2020-12-22
- Target Recruit Count
- 81
- Registration Number
- NCT03855891
- Locations
- 🇷🇺
IMSechenovMMA, Moscow, Russian Federation
One-Dimensional Mathematical Model-Based Automated Assessment of Fractional Flow Reserve
Not Applicable
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: FFR
- First Posted Date
- 2019-01-08
- Last Posted Date
- 2020-05-18
- Target Recruit Count
- 31
- Registration Number
- NCT03797118
- Locations
- 🇷🇺
Daria Gognieva, Moscow, Russian Federation
Thulium Fiber Laser Enucleation of the Prostate (ThuFLEP): Efficacy and Safety
Not Applicable
- Conditions
- Prostatic Hyperplasia
- Interventions
- Procedure: Thulium Fiber Laser Enucleation of the ProstateDevice: Thulium Fiber Laser "Urolase"
- First Posted Date
- 2018-06-12
- Last Posted Date
- 2021-07-22
- Target Recruit Count
- 500
- Registration Number
- NCT03554070
- Locations
- 🇷🇺
Clinic of Urology, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation
Efficacy and Safety Assessment of IRE of Localized Prostate Cancer.
Not Applicable
Completed
- Conditions
- Prostate AdenocarcinomaProstate Cancer
- Interventions
- Device: Focal irreversible electroporation of the prostate cancer
- First Posted Date
- 2018-04-20
- Last Posted Date
- 2020-07-28
- Target Recruit Count
- 10
- Registration Number
- NCT03504995
- Locations
- 🇷🇺
Clinic of Urology, Sechenov University, Moscow, Russian Federation
Effectiveness of BBT-I and Zopiclone for Chronic Insomnia
Phase 2
Completed
- Conditions
- Insomnia Chronic
- Interventions
- Behavioral: Brief behavioral therapy
- First Posted Date
- 2017-11-13
- Last Posted Date
- 2019-09-16
- Target Recruit Count
- 42
- Registration Number
- NCT03339583
ThuLEP vs. HoLEP vs. Monopolar Enucleation in Management of BPH
Not Applicable
Completed
- Conditions
- Prostatic Hyperplasia, BenignLower Urinary Tract SymptomsProstate Adenoma
- Interventions
- Procedure: Monopolar enucleation of the prostateProcedure: Thulium-fiber laser enucleation of the prostate
- First Posted Date
- 2017-07-26
- Last Posted Date
- 2017-07-28
- Target Recruit Count
- 450
- Registration Number
- NCT03230721
Tissue-engineered Construct Based on Buccal Mucosa Cells and Matrix From Collagen and Polylactoglycolide Fibers
Early Phase 1
- Conditions
- Urethral Stricture
- Interventions
- Procedure: Urethroplasty with a tissue-engineered construct
- First Posted Date
- 2017-07-02
- Last Posted Date
- 2020-02-17
- Target Recruit Count
- 6
- Registration Number
- NCT03205670
- Locations
- 🇷🇺
Sechenov University, Moscow, Russian Federation
© Copyright 2025. All Rights Reserved by MedPath